Ubiquigent Ltd
- Small
- Holding
- Active
- 15 years
- 12 employees
- £625,586 (assets)
- Real address
- 6 directors
- 2 owners
- Regular importer
- Regular exporter
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Website
Social media
Phones
Summary
Ubiquigent Ltd, based in Dundee, UK, is a small, holding company with an active status. Founded fifteen years ago in 2009, the company employs twelve people and holds £625,586 in assets. It has six directors and two owners, and operates from a real address at Dundee University Incubator. The company regularly imports miscellaneous chemical products (for three months) and exports natural and modified starches, glues, and enzymes (for twenty-two months).
The company's website highlights its focus on ubiquitin-targeted drug discovery and development. Ubiquigent offers a platform of reagents, services, and partnerships aimed at researchers and pharmaceutical companies. They specialize in DUB enzymes and the ubiquitin-proteasome system (UPS), providing assays, expertise, and capabilities for drug development. The site emphasizes an "unrivaled track record" and a focus on the exploitation of DUB enzymes.
Financially, Ubiquigent Ltd’s recent performance reveals a mixed picture. Current assets have significantly decreased by 56%, falling to £630,000. Net assets have also declined substantially, dropping 60% to £540,000. Cash reserves have plummeted 80%, leaving just £190,000. Trade debtors have decreased by 22%, which could indicate improved collection efforts. The company’s small size (meeting two of three conditions for a small company) allows for agility, but the sharp decline in cash and equity raises concerns. As a small company, it is exempt from an audit, so the figures are unaudited.
The company’s focus on a niche scientific field suggests a high-value, specialized business, but the financial data indicates potential challenges in managing cash flow and maintaining equity. It’s possible that investment in research and development is impacting short-term profitability, but the long-term potential of ubiquitin-targeted drug discovery could outweigh these concerns.
Registered in Scotland under the registration number SC362461, with a registered address at DD1 5JJ, Dundee, Dundee University Incubator Dundee Technopole, James Lindsay Place.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Corporate
- 7 years
- 25%+
-
Resident of United Kingdom
-
Corporate
- 8 years
- 19
- 25%+
-
Resident of United Kingdom
Managers
-
Individual
- 3 years
-
Resident of United Kingdom
-
Corporate
- 5 years
- 14
-
Resident of United Kingdom
-
Individual
- 9 years
- 3
-
Resident of United Kingdom
-
Individual
- 10 years
-
Resident of United Kingdom
-
Individual
- 11 years
- 7
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted eleven months ago.
Last news
-
Confirmation statement made on 2024-08-02 with updatesDownload 6 pages pdf report
-
Total exemption full accounts made up to 2023-12-31Download 12 pages pdf report
-
Statement of capital following an allotment of shares on 2024-02-12Download 3 pages pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
Similar importers
- Company names
- HS codes
- Financial data
- Officers and owners
Exporter profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last exported products
Click on items to see detailed UK statistics on HS code, including companies list.
Similar exporters
- Company names
- HS codes
- Financial data
- Officers and owners
FAQ about Ubiquigent Ltd
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!